Storys zum Thema Medizin

Folgen
Keine Story zum Thema Medizin mehr verpassen.
Filtern
  • 17.06.2025 – 13:31

    Isomorphic Labs

    Isomorphic Labs appoints Dr. Ben Wolf as Chief Medical Officer and establishes US Presence

    London and Boston (ots/PRNewswire) - Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. Isomorphic Labs, the AI-first drug discovery company, has announced the appointment of Ben B. Wolf, M.D., Ph.D., as Chief Medical Officer. Dr. Wolf will be based in the company's newly ...

  • 17.06.2025 – 09:02

    MedHub; Terumo

    MedHub-AI and Terumo partner to market AI-based FFR in Japan

    Tel Aviv, Israel (ots/PRNewswire) - MedHub-AI, pioneer of AI-based FFR "AutocathFFR" software, today announced a distribution agreement with Terumo Corporation to bring AutocathFFR®, its groundbreaking AI-powered Software as a Medical Device (SaMD), to the Japanese market. This partnership marks a new era in coronary physiology assessment where AI technology delivers superior confidence, reproducibility, and clinical ...

  • 16.06.2025 – 13:40

    Innovative Molecules GmbH

    Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250

    Munich (ots/PRNewswire) - Innovative Molecules GmbH Announces Completion of Phase 1b Enrollment for IM-250 in Genital Herpes Clinical Trial Innovative Molecules GmbH today announced the completion of enrollment in the Phase 1b portion of its ongoing Phase 1b/2a clinical trial evaluating IM-250, a next-generation helicase-primase inhibitor targeting herpes simplex virus ...

  • 04.06.2025 – 10:01

    Healthcare Holding Schweiz AG

    Healthcare Holding Switzerland Acquires Ino Medical Solutions

    Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio with the acquisition of Ino Medical Solutions GmbH. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH and KKA Partners. Healthcare Holding Schweiz AG has successfully completed the acquisition of Ino Medical Solutions GmbH, based ...

  • 02.06.2025 – 11:39

    BIAL SA

    BIAL Announces Oral Presentation at GBA1 Meeting 2025

    Porto, Portugal (ots/PRNewswire) - BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at the GBA1 Meeting 2025 being held June 5-7, 2025, in Montreal, Canada. The GBA1 Meeting 2025 is hosted by McGill University, focusing on all aspects of GBA1 research, from basic ...

  • 06.05.2025 – 15:17

    Healthcare Holding Schweiz AG

    Healthcare Holding Switzerland Acquires Aestheticbedarf

    Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio with the acquisition of Aestheticbedarf AG. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH. Healthcare Holding Schweiz AG has successfully closed the acquisition of Aestheticbedarf AG, headquartered in Affoltern, an ...

  • 30.04.2025 – 10:09

    Healthcare Holding Schweiz AG

    Healthcare Holding Switzerland Acquires CDP Swiss

    Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Schweiz AG, a leading provider of services and distributor of medical technology in Switzerland, has expanded its portfolio by acquiring CDP Swiss AG and CDP Austria GmbH. Healthcare Holding Schweiz is managed by Winterberg Advisory GmbH. Healthcare Holding Schweiz AG has successfully closed the acquisition of CDP Swiss AG, based in Affoltern, and its subsidiary, CDP ...

  • 29.04.2025 – 09:00

    Acousia Therapeutics GmbH

    Acousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study

    Tübingen, Germany (ots) - Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention of cisplatin-induced hearing loss in patients with testicular cancer undergoing chemotherapy. Cisplatin is a cornerstone in modern oncology and ...

  • 28.04.2025 – 11:32

    Scantox A/S

    Annual Report 2024 released by Scantox Group

    Ejby, Denmark (ots/PRNewswire) - Scantox Group has released their 2024 Annual Report today. It highlights the many activities the company has done over the year to shape the future of a business that in so many ways contribute to improve lives worldwide through the development of new drugs and treatments. "Our 2024 result shows high profitable growth from transformational acquisitions. We are very pleased with these ...

  • 15.04.2025 – 11:35

    Healthcare Holding Schweiz AG

    Healthcare Holding Switzerland Acquires Schaublin Medica

    Baar, Switzerland (ots/PRNewswire) - Healthcare Holding Switzerland AG, a leading provider of services and distributor of medical technology in Switzerland, has strengthened its portfolio with the acquisition of Schaublin Medica SA. Healthcare Holding Switzerland is managed by Winterberg Advisory GmbH. Healthcare Holding Switzerland AG has successfully completed the acquisition of Schaublin Medica SA. As part of a ...

  • 11.04.2025 – 07:00

    Gerresheimer AG

    Gerresheimer: Bormioli Pharma boosts revenues and earnings

    Düsseldorf (ots) - - Revenues +11.6%, Adjusted EBITDA +13.1% - Organic development compared to pro forma figures Q1 2024: revenues -6.5%, adjusted EBITDA -9.3% - Q1 significantly influenced by revenue shift in syringe business - Guidance 2025 confirmed: organic revenue growth of 3-5% and adjusted EBITDA margin of 22% Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and ...